This paper analyses the main narratives, rhetorical resources and themes deployed during public contemporary debates on stem cell research (SCR) and cellular therapy in Brazil, an emergent global player. It examines the discursive rhetoric used to discuss adult and embryonic stem cell research and analyses the processes and main themes involved in the approval of the 2005 Biosecurity Law at the National Congress and, more specifically, during the 2007 public hearing at the Federal Supreme Court. Relying on previous academic work and supported by the analysis of public audiences´ transcriptions, key journal reports and 15 semi-structured face-to-face interviews, the paper focuses mainly on the common topics in the scientists´ narratives to map the characteristics of the Brazilian debates and establish the main convergences and divergences between the positions taken by opposing lobbies. These are illustrated by selected statements on recurrent themes and assumptions. There are three main areas of focus: forms of scientific, technical and moral construction of discourse and regulation; strategies towards civil society´s engagement and participation; and the country´s contributions to global genetics and health biotechnology. The paper argues that the specificities of the narratives deployed by the different social actors are a product not solely of sociocultural and religious backgrounds and practices, but also of local SRC development and social awareness, of the exercise of citizens´ rights, and of prevalent cultural trends in the local relations between science, medicine and society.
Introduction
Stem cell research (SCR) has increasingly become a global activity, 2 in which initiatives from the industrialised and emerging economies promise important socioeconomic contributions, mainly through the design of new therapies for noninfectious disease that has increased among ageing populations, also within the developing world. 3 The use of embryonic stem cell lines as an innovation trajectory in research and isolated clinical trials, has given rise to international controversies relating to embryo use and disposal. 4 These debates are also relevant for: the sustainability of high-risk experimental research in developing countries and for their technological choices, as well as, for the information on health-care the local 'publics' have access to and which they need in order to be able to participate as informed citizens in policy-making. Some of the technologies being researched by industrialised countries are being tested in emerging economies under dubious conditions. 5 Future technological and regulatory regimes will articulate and influence each other. 6 This paper examines the discursive rhetoric used during public debates on adult and embryonic stem cell research in Brazil and analyses the main themes and contents involved in the approval of the 2005 Biosecurity Law (Lei nº 11.105) at the National Congress and, more specifically, during the 2007 public hearing (ADIn 3510) at the Federal Supreme Court. The analysis focuses mainly on the common themes found in the scientists´ narratives 7 to map the characteristics of the Brazilian debates and to establish the main convergences and divergences between the positions taken by opposing lobbies and the discourses each of them developed to engage public opinion (illustrated by selected statements on recurrent themes and assumptions). The paper argues that the specificities of the narratives deployed by the different social actors are a product not solely of sociocultural and religious backgrounds and practices, but also of local SRC development and social awareness, of the exercise of citizens´ rights, and of prevalent cultural trends in the local relations between science, medicine and society.
Stages in the approval of the Brazilian 2005 Biosecurity Law
In Brazil, a very long process of negotiation and public debate was required to change the 1995 Biosecurity Law (Lei nº 8.974) and approve its replacement (Lei nº 11.105). The legislative process included the following events: the approval of the first law on biosecurity (the 1995 law), the creation of a National Technical Commission on Biosecurity 8 and challenges against its decisions on genetically modified organisms (GMOs) There were four distinct phases to this approval process, based on different social appraisals on biosecurity and on changing relations between science, medicine and society. 9 Between 1997 and 2003, under increasing social pressure for regulation, the government sought approval of a law governing transgenic crops and foods. A vacuum of regulatory frameworks had facilitated agribusiness firms´ illegal commercialisation of several types of GMOs, mainly soya, cotton and maize. Local stem cell research had begun around 1999, promising many useful results for different medical fields. At that time, health innovation was developing within a generally positive context, due to the creation of the national public health system (Sistema Único de Saúde -SUS) in 1990, based upon the principle of healthcare for all free at the point of service. A basic trust relationship had been established between science, medicine and society, in spite of certain specific health controversies.
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In 2003, the biosecurity law reform project was drafted. At the time, there was no specific federal law-and, indeed, to date there is still no specific law 11 -to regulate the use of human embryos in research or assisted reproduction, although assisted reproduction has been expanding steadily since the early 1980s. This reform project was seen as an opportunity to negotiate the conditions for the approval of transgenic crops, together with that of embryonic stem cell research (ESCR).
During initial negotiations, the legal ban on ESCR, based on Article 6 of the 1995 Biosecurity Law, banning the production, banking and manipulation of human embryos, was upheld. However, the ban was lifted when the 2003 law reform project was sent to the Deputy Chamber of Congress. Those opposing the ban, a majority in number and highly politically influential, reacted strongly. Within the Deputy Chamber of Congress opponents, grouped into two well-organised blocs, namely the Catholics (Bancada Católica) and the evangelicals (Frente Parlamentar Evangélico -FPE) -both aligned with anti-abortion groups -made an agreement to modify the latest draft of the bill, basing their decision on their religious convictions.
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Between 2004 and 2005 those in favour of ESCR became better organised. Their lobby was composed mainly of scientists, patient organisations, individual severely ill patients and some (publicly prominent) disabled patients and their relatives, the latter grouped in the main Brazilian patient organisation: MOVITAE (Movimento em Prol da Vida).
14 The scientific community in favour of ESCR and the other active organisations-including a highly visible group of local patients who could eventually benefit from SCR-formed an alliance with the lobby favourable to the cultivation of GMOs in Brazil, with whom they shared a similar strategy for the approval of regulation relevant to both topics.
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Scientists from this lobby were invited to the 2004 public hearing at the Senate Chamber of Congress (one of the two Chambers in Congress, the other being the Deputies´ Chamber). They pursued a pragmatic strategy, presenting detailed research reports and making repeated references to 'the opportunity for a humanitarian use' of surplus and unviable frozen embryos in research. These were estimated at between 20-30,000, which later proved to be a major overestimate. Scientists construed the disposal of frozen embryos as an inevitable daily and pre-existing by-product of the work of the fertility clinics, and defended ESCR as important to maintain and improve Brazil´s position in the biotechnology race and as a way of reducing public health expenditure in the future. Conceptual and ethical debates on embryo status were avoided, as well as all reference to ethically controversial techniques, such as therapeutic cloning. Some representatives at the Senate supported the scientists´ arguments and expressed their faith in the capacity of the scientists to obtain future benefits, such as those promised by cellular therapies. 16 They considered scientific narratives to be neutral and attributed unique authority to them, vis-à-vis other forms of knowledge, as had been the case during previous discussions on GMOs. Article 5 , which established the conditions under which ESCR was allowed to be carried out. These were apparently considered too liberal by the anti-ESCR lobby, whose central assumption, that human life begins at conception, for them a moral and religious conviction, was shared by the attorney-general.
Article 5 of the approved law authorised the derivation of ESC from surplus embryos from in vitro fertilisation, if frozen for three or more years at the date of publication of the law; in-vitro embryos not yet frozen at that date could be used for research only after a three-year freezing period. The law also established the need for parental written informed consent (Art.5º, §1º) and for research institutes and health services working with ESC to submit their projects for approval to the relevant research ethics boards (Art.5º, §2º). 
Format and Implementation
The presiding justice, Carlos Ayres Britto, a practising Catholic, decided to hold a public hearing on 24 April 2007, the first in the STF's history, 18 in order to: "listen to presentations from people with experience and authority". 19 Explicitly, the hearing was intended to address the STF´s doubts, widen its technical knowledge and increase civil society´s participation in a socially relevant topic. Implicitly, the hearing was intended to increase the legitimacy of the STF´s decisions. 20 Twenty-two specialists were selected to present 20-minute individual research reports. These scientists were equally divided into two well-characterised opinion blocs: one against and one favourable to the lawsuit. A debate strategy was followed that conflated those against and in favour of the lawsuit with those against and in favour of ESCR. This arrangement was effectively a political strategy, as there could be only two sets of 'valid' opinions expressed among those scientists engaged in this specific debate on SCR in Brazil.
Each bloc was assigned a little over two hours for presentations. 21 There was no room for debate after each presentation or after each bloc's contributions; the discussion of ideas, views and positions was explicitly dissuaded, as part of the rules of proceedings of the STF on public hearings. The participants were not free to raise questions; they were there to answer the questions posed by the public attorney in the lawsuit and to inform the justices about facts and ethical/moral positions related to these questions.
However, some justices characterised the hearing as: The format of the hearing hampered the very practice that defines public debate, and was shaped in ways distant from "an example of democracy" 24 ; notwithstanding its value as a deliberative, informational and educational tool. The "stage of collective decision-making" 25 was occupied by the justices, with the support of a new epistemic scientific group. 26 The strategy adopted was not necessarily the best one to obtain a democratically negotiated consensus for collective decision-making.
Civil society´s actual engagement preceded the public hearing. NGO representatives and patients made trips to Brasilia, camped and convened meetings in front of the Supreme Court building, published reports in key national newspapers and on the web sites of participating organisations, and were interviewed on TV.
Social actors' initiatives tend to reflect the different civic epistemologies of the culture where the debate takes place. 27 In the Brazilian case, they expressed contradictory and ambivalent social and moral/ethical beliefs within a culture undergoing a transition towards a more inclusive democracy.
Definitions of human life and of science
Ontological perspectives on the beginnings of human life and on the status of the embryo, perspectives that had been relatively silenced by ESCR supporters towards the end of the 2005 law approval process, were brought to the forefront at the public hearing. The two central questions asked by the justices were about the definition of unviable research embryos and about the ideal freezing period for embryos.
The different meanings of human 'life' were obscured in the specialists' presentations. Polarities between 'good' and 'bad' science and 'science' and 'nonscience' were used to mask those meanings, and also to create new boundaries for the ESCR field. For example, when the importance of the three-year freezing period for research embryos was discussed, frontier-lines were drawn in each camp using opposite framings: the rights of the parents versus the rights of the embryo. ESCR supporters argued in terms of the ideal time for the parents to make an informed and definite decision on embryo donation. By contrast, their opponents argued that establishing a fixed period was intended to avoid the cloning of research embryos, as well as, embryo commerce and research fraud.
ESCR opponents also expressed a perspective of nature as 'untouched' by culture, contrary to contemporary views on the mutual co-construction between nature and culture and of scientific facts. 28 When working from within nature´s approach is abandoned, all other definitions become arbitrary and there is a lack o f any framework to take any decision (Lenize Aparecida Martins Garcia, a biologist and professor and a practising Catholic). 29 This camp also tried to discredit their adversaries' position on the decrease in frozen embryos' viability for human reproduction over time, through repeated reference to successful reports on Brazilian children born as a result of in-vitro fertilisation using embryos frozen for periods between six and 12 years 30 31 . ESCR opponents also argued that the division between viable and unviable embryos led to an inappropriate classification into two types of people: normal and inadequate.
Meanwhile, ESCR supporters characterised life as relational, gradual and in evolution, severing all its connections with embryo life. They also supported research on embryos selected through an 'objective' embryo-grading at the in-vitro fertilisation clinics 32 33. Each group was suspicious of the data, evidence and scientific methods of the opposing bloc. ESCR opponents grounded their concerns about embryo research in what they described as, the "unanimous definitions within biology's respectable literature" about the beginnings of human life 34 . Among the defenders, perspectives on human life and its hierarchies were contradictorily expressed: the embryo became 'a subject of its own decisions':
There is n o life in the frozen embryo if there is no hum an intervention ... W e are defending that in the sam e way as an individual with cerebr al death can donate orga ns, a frozen em bryo could donate its cells (Mayana Zatz, a Jewish geneticist by back ground and embryonic SC scientist). 35 Two striking features characterise the debate on this issue in Brazil. First, the differentiation between pre-embryos and embryos, based upon the shaping of the initial neurological system at around day 14 of embryo development, is used internationally to justify ESCR with cells collected at the 'pre-embryo' stage. But this distinction was absent from the discursive strategies deployed. Second, an internationally prevalent paradigm shift in conventional perspectives about the initial unit of life had only minor relevance in the Brazilian context. This shift corresponds to that between a social perspective that considers embryos as the initial unit of human life, and that which assigns this place to the stem cell. 36 (In Brazil, this perspective still generates strong public opposition). Brazilian narratives focused upon drawing a boundary between viable in-vitro surplus embryos as potential initial units of life, and embryos unviable for assisted reproduction, reflecting dominant Christian religious and moral beliefs.
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The shaping of a new epistemic scientific community SC scientists working with adult cells formed part of both blocs, but expressed opposite views. Those opposed to ESCR framed their arguments in relation to the lack of international therapeutic applications of embryo research, and/or to its risks, and emphasised the potential of adult SCs to substitute for embryonic SCs. Only one scientist in this group mentioned the potential of human induced pluripotent cells (iPS), 38 to substitute for ESC. 39 This limited reference to iPS may have partly reflected the fact that international research on these cells was relatively new. Successful derivation of human iPS was only publicly reported in November 2007 40 .
Among ESCR supporters, those researchers who only worked with adult SCs indicated their interest in extending their work to embryonic cells because of their higher plasticity and potential to regenerate organs 41 , and only one scientist in this group referred to the future advantages of iPS as they do not involve embryo manipulation 42 . Some speakers explained that what was being used in research was a mass of cells and not the embryo itself 43 . As this camp was trying to defend embryo research experimentation, they adopted an explicit strategy to focus on ESCR, instead of overtly and extensively referring to the potential benefits of iPS.
The 'morality-immorality' of using research embryos was also set against the scientists´ moral responsibility by this group:
Responsibility lies within the one that recognises the therapeutic potential of embryo stem cells but blocks or does not prom ote its study. We cannot shirk our responsibility of working with embryonic SCs (Stevens Kastrup Rehen, a Catholic by background and an atheist embryonic SC scientist). 44 Technical and ethical aspects of ESCs divided Brazilian adult SCs´ researchers. However, an intense rivalry did not develop between the two scientific communities, as has been documented in other countries. 45 Narratives show that the field itself is still under definition locally, as a new and smaller epistemic community is being shaped, namely one that tends towards cooperation between research insti 46 tutes.
Social and gender roles: motherhood, infertility and abortion
Social and gender attributes, particularly with regard to infertility and motherhood permeated the debates, though for opposite reasons within each camp. The opposing bloc considered that:
To be sure that an em bryo is viable or not, the only way to give it a chance is f or it to be im planted. The point is that when several embryos are implanted not all are viable and develop till the end of gestation (Lenize Aparecida Martins Garcia, a practising Catholic and a professor of biology). 47 The defending bloc framed embryo research donation as a socio-ethical responsibility:
What is ethically correct? To preserve frozen em bryos, even knowing that their probability of generating a hum an being is practically zero, or dona te them for re search that could result in future treatments? (Mayana Zatz) 48 The embryo was construed as a direct contributor to the wellbeing of present and future generations specially in one narrative (Deborah Diniz , a Catholic by background and an atheist, a leading bioethicist and anthropologist). 49 Positions upheld by both blocs converged in their disregard for the perspectives of research embryo donors. While one bloc defended the parents´ obligation to allow embryos to grow into babies, the other emphasises the parents' social responsibility to support the development of future therapies based on embryo donation for research. The parents´ own perspectives on embryo research are absent from these narratives.
Scientists also assumed, without offering evidence, that assisted fertilisation patients would agree to donate to ESCR. Estimates on sources of ESCR are based on the number of surplus embryos frozen within assisted fertilisation clinics, without knowing, whether and under what conditions and for what types of research, parents would consent to donation. Important motivations for embryo research donations, such as research aimed at the advancement of reproductive medicine, infertility treatment and embryo abnormality detection, were not mentioned during the local debates. 50 Two important aspects of embryo donation for research were excluded from the debate: a) the potential coercive or inducement effects on donations of the doctorpatient or researcher-patient relationship; and b) the potential technical arbitrariness in embryo-grading, resulting from non-standardised classifications between fertility clinics.
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The opposing camp made a direct association between ESCR and abortion, a practice prohibited and criminalised in Brazil. Pre-existing sociocultural perspectives, transposed from abortion debates, permeated the arguments. References and analogies were made to 'pro-life' arguments. ( The foetus was portrayed as feeling pain and influencing the mother´s psyche and hormones very early on; the mother as having a very early communication with the embryo/foetus.) 53 Hegemonic social attributes based on gender relations dominated the debate, including women's social role as mothers and also as research donors. 54 These attributes are interwoven into a referential framework developed almost exclusively by the scientific and medical establishment, defended as being superior, or the 'only discourse with authority'; 55 and given priority above other forms of knowledge, including that of the genitors of potential research embryos.
Infertility, for both blocs, consequently becomes a valuable source of biological research materials and is repositioned within culturally hegemonic social perspectives. 56 Infertile Brazilians, especially women, are directly or indirectly asked to work towards 'the common good'.
National competition in genetics and health biotechnology
The rhetoric of the debate transmitted a certain hastiness to approve ESCR associated with Brazil´s international position in this field. ESCR supporters focused upon the global use of embryonic SCs to develop or test drugs and medicine, intellectual property rights protection and the Brazilian poor future lack of access to international SC-based drugs and therapies. 57, 58 This group argued that the 2004 National Science, Technology and Innovation Plan 59 had established biotechnology -including SCR -as one of its strategic priorities, thus providing the opportunity to develop advanced technology locally. 60 One of the main convergence zones between the blocs during the public debates was national pride in the country´s SCR with adult cells, particularly its global role:
Brazil is th e world cha mpion in re lation to th e diversity of clinical applications using adult SCs ... it is one of the leading countries in the world that cu res its patients with th ese therapies (Rogerio Pazetti, a practising Catholic and a biologist and adult SC scientist). 61 Some of the pioneering local scientists in adult SCR formed part of the defence group (e.g. Antonio Campos de Carvalho, director of the National Network of Cellular Therapies and of the National Multicentre Random Trial on Heart Disease). 62 Strategically, the opponents emphasised the discourse on Brazil´s leading role in adult stem cells, to try to ban embryonic stem cell research.
During the debates on Brazil´s global competition there were some key omissions. These included: potential public access to the eventual local cellular therapies; the prospective costs of these therapies; future relations with the biotechnology industry; potential ethnic and racial discrimination; 63 and eventual commercial uses of these therapies for cosmetic ends. 64 
Stem cell research debates revisited
The Brazilian debates show some relevant local trends and social positions in relation to at least the following three topics: forms of scientific, technical and moral construction of discourse and regulation; social views on civil society´s engagement; and perceptions on Brazil´s contributions to global genetics. These topics will be briefly addressed taking as points of comparison relevant public SCR debates in other contexts and the wider Brazilian health and/or development context. The Brazilian public debates on SCR are relatively recent compared with most European and other developed countries, 65 and do not form part of a structured public revision of human reproduction and genetic institutions and regulation. Many countries pioneering ESCR concentrate on the difficulty in establishing adequate regulatory frontiers for research objects that defy traditional rules and codes of practice. 66 This is also the case in Brazil, in relation to one central aspect of the public debates: the use of viable and unviable embryos for experimentation.
The 'embryo question' plays a dominant role in defining the content of the different local debates. The interpretations made, based on sociocultural and religious backgrounds (root religion or regularly practised religion -as acquired through family background and/or education and not necessarily being practised), determine specificities within these positions. Pragmatic perspectives dominant among defenders of ESCR are supported by ontological positions that are not so clearly defined and, sometimes, juxtapose and articulate elements of different approaches to life within a single argument. Brazilian opponents of ESCR articulate their exploration of biological facts and of related ethical frameworks and ontological references more coherently within their own perspective, but less systematically.
Only sporadic elements of an ontological paradigm shift from the human embryo to the stem cell as the initial unit of life, key to other societies' debates, are found in the Brazilian context. 67 Also, the definition of hierarchies and grades between types of human research embryos, for example, between viable and unviable frozen and fresh embryos, although addressed by ESCR advocates, does not become a central axis of debates. 68 However, Brazilian debates largely converge with narratives in other countries´ SCR public debates in their utilitarian approach, emphasising the potential service that invitro embryos might offer to society or to specific patients. Even among ESCR opponents, where Catholicism plays a central role in perceptions and narratives, a certain utilitarian perspective also prevails. However, when the Catholic religion is acquired by background and not regularly practised -as reflected in some of the narratives among ESCR defenders -the utilitarian approach apparently becomes even stronger; and it is even more marked among atheists.
Brazilian perspectives on scientific and technical progress tend to deal with scientific discourse as a form of 'authoritative knowledge', and narratives tend to reflect structured and quite evenly distributed cultural beliefs on trust in scientific and technological paths. The discursive tactics and strategies used for the construction of new frontiers in this field, reveal the use of dichotomies such as, 'science' and 'nonscience' and 'good' or 'bad' science, which play quite a central role in the controversies, and are supported by abundant references to international practices. However, there is no significant initiative to build a coherent and institutionally referenced scientific, technical and ethical framework that could give rise to distinct new concepts and vocabulary -e.g. that of 'pre-embryos'-which would be useful to establish some uniformity and eventually generate points of inflection in the public debates, 69 as well as contributing substantially to the design of new regulations.
Politicisation of public health and ethics is a common feature of Brazilian public debates on different health topics. 70 In the case of ESCR, morality is used as a resort and polarised between: the embryo versus the suffering patients or their families, or the rights of the embryo versus the scientists' responsibilities. The potential patients are represented as being desperate for cures, despite a lack of consultation with some key patient groups and organisations for people with disabilities. For example, the multiple demands posed by international patient organisations, or individuals, defending their condition of disability or sensorial deprivation and their rights to an intergenerational transmission of selective forms of disability have not been addressed by the public debates in Brazil. 71 This topic could have been discussed at the Supreme Court hearing by having some speakers to counterbalance the dominant perspective in which people with disabilities were portrayed as desperate for new SCR therapies.
Lobbies for and against ESCR try to engage the 'publics' through a 'hype and hope' strategy ( meaning the use of information and emotional tones that exaggerate the benefits and delivery-times of potential therapies and cures and thus 'hype' eventual users´ expectations and hopes), 72 but in significantly different ways. The ESCR defenders´ lobby mainly targets patients and families, while the opposition lobby mainly targets anti-abortion and religious groups. Also, Brazilian 'bottom up' public engagement campaigns on SCR are different to those in other countries. They have been based upon short-term lobbying strategies and voluntary public advocacy, rather than upon a stable and solid participation process and institution-building for policy decision-making. 73 In general, Brazilian patient organisations are smaller than, for example, most US or European equivalents, and are less active and articulate in public debates. 74 The SCR 'publics' are drawn mainly from a: 'deficit top-down model' 75 and, even though the Brazilian Government develops public consultation of concerned stakeholders for specific SCR topics, it lacks an appropriate design for an inclusive public consultation strategy. The voices of specific social movements in the public arena 76 have been reduced to a minimum in past SCR public debates, with some exceptions. 77 The Brazilian 'publics' are involved in these debates in ways that show a transition and/or disparity between the exercise of civil rights within a representative democracy, and within a direct and participatory democracy. 78 Scientists' narratives on Brazil´s global participation in genetics and biotechnology are constructed with reference to the country´s international competitiveness and are intended to promote the acceptance of scientific progress in SCR. Cellular therapies are measured in terms of their potential for disease treatment and for the country´s competitiveness. This field is seen as an opportunity for Brazil´s international expansion, so the country´s national success in adult SCR tends to be 'hyped.'
There was an important omission in the construction of the National Congress public debates, the potential commercialisation and distribution of the eventual embryobased cellular therapies, a central issue for an emerging economy that seeks both better public health therapies and greater leadership in the international arena. This topic was not significantly addressed within the SFT public hearing either by the justices or the speakers. Given the rate of local innovation and developments in the area, 79 it is particularly relevant to focus on this aspect in the future, i.e. the potential participation of the biotechnology and pharmaceutical industries in the development of SCR-based therapies for the public health system. (CTNBio) . 9 The overall period between 1995 and 2008 also corresponds to different governments, each supporting different socioeconomic models and perspectives on democracy, social participation and national biosecurity policy, under the presidencies of Fernando Henrique Cardoso (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) , and Luiz Ignacio da Silva (Lula) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) . 10 For example, inefficient implementation of the new public health system and inefficacies in the prevention and treatment of HIV/AIDS, had already been contested by different civil society organisations. (Re)Constructing embryos in stem cell research: Exploring the meaning of embryos for people involved in fertility treatments 51 Scientists largely granted authority for the implementation of decisions on embryo research donations to the in-vitro fertilisation clinics rather than to the parents themselves. In contrast, ESCR opponents regarded assisted fertilisation as embedding new moral values which they considered as a setback for contemporary civilization.
